Common Variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP Are Associated with Alzheimer's Disease

We sought to identify new susceptibility loci for Alzheimer's disease through a staged association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease Genetic Consortium (ADGC) in a companion paper. We undertook a combined analysis of four genome-wide association datasets (stage 1) and identified ten newly associated variants with P ≤ 1 × 10(-5). We tested these variants for association in an independent sample (stage 2). Three SNPs at two loci replicated and showed evidence for association in a further sample (stage 3). Meta-analyses of all data provided compelling evidence that ABCA7 (rs3764650, meta P = 4.5 × 10(-17); including ADGC data, meta P = 5.0 × 10(-21)) and the MS4A gene cluster (rs610932, meta P = 1.8 × 10(-14); including ADGC data, meta P = 1.2 × 10(-16)) are new Alzheimer's disease susceptibility loci. We also found independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance: CD2AP (GERAD+, P = 8.0 × 10(-4); including ADGC data, meta P = 8.6 × 10(-9)), CD33 (GERAD+, P = 2.2 × 10(-4); including ADGC data, meta P = 1.6 × 10(-9)) and EPHA1 (GERAD+, P = 3.4 × 10(-4); including ADGC data, meta P = 6.0 × 10(-10)).

Citing Articles

Phagocytosis-driven neurodegeneration through opposing roles of an ABC transporter in neurons and phagocytes.

Chen X, Wang B, Sarkar A, Huang Z, Ruiz N, Yeung A Sci Adv. 2025; 11(11):eadr5448.

PMID: 40073145 PMC: 11900885. DOI: 10.1126/sciadv.adr5448.

CD22 modulation alleviates amyloid β-induced neuroinflammation.

Mai Y, Zhang Q, Fung C, Leung S, Chong C J Neuroinflammation. 2025; 22(1):32.

PMID: 39910617 PMC: 11800469. DOI: 10.1186/s12974-025-03361-2.

The impact of rare genetic variants on Alzheimer disease.

De Deyn L, Sleegers K Nat Rev Neurol. 2025; 21(3):127-139.

PMID: 39905212 DOI: 10.1038/s41582-025-01062-1.

Alzheimer's disease risk ABCA7 p.A696S variant disturbs the microglial response to amyloid pathology in mice.

Ma X, Prokopenko D, Wang N, Aikawa T, Choi Y, Zhang C Neurobiol Dis. 2025; 206:106813.

PMID: 39880319 PMC: 11884743. DOI: 10.1016/j.nbd.2025.106813.

The ABC transporter A7 modulates neuroinflammation via NLRP3 inflammasome in Alzheimer's disease mice.

Santos-Garcia I, Bascunana P, Brackhan M, Villa M, Eiriz I, Bruning T Alzheimers Res Ther. 2025; 17(1):30.

PMID: 39871385 PMC: 11773842. DOI: 10.1186/s13195-025-01673-2.

References

Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View

Kamboh M, Minster R, Demirci F, Ganguli M, DeKosky S, Lopez O . Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging. 2010; 33(3):518-21. PMC: 3010357. DOI: 10.1016/j.neurobiolaging.2010.04.015. View

Mirra S, HEYMAN A, McKeel D, SUMI S, Crain B, Brownlee L . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41(4):479-86. DOI: 10.1212/wnl.41.4.479. View

Tateno H, Li H, Schur M, Bovin N, Crocker P, Wakarchuk W . Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity. Mol Cell Biol. 2007; 27(16):5699-710. PMC: 1952126. DOI: 10.1128/MCB.00383-07. View

Kim W, Guillemin G, Glaros E, Lim C, Garner B . Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. Neuroreport. 2006; 17(9):891-6. DOI: 10.1097/01.wnr.0000221833.41340.cd. View

Jun G, Naj A, Beecham G, Wang L, Buros J, Gallins P . Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010; 67(12):1473-84. PMC: 3048805. DOI: 10.1001/archneurol.2010.201. View

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-9. PMC: 2855889. DOI: 10.1038/nmeth0410-248. View

Corneveaux J, Myers A, Allen A, Pruzin J, Ramirez M, Engel A . Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010; 19(16):3295-301. PMC: 2908469. DOI: 10.1093/hmg/ddq221. View

10.

Saunders A, Strittmatter W, Schmechel D, Pericak-Vance M, Joo S, Rosi B . Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993; 43(8):1467-72. DOI: 10.1212/wnl.43.8.1467. View

11.

Martinez A, Soriano E . Functions of ephrin/Eph interactions in the development of the nervous system: emphasis on the hippocampal system. Brain Res Brain Res Rev. 2005; 49(2):211-26. DOI: 10.1016/j.brainresrev.2005.02.001. View

12.

Dustin M, Olszowy M, Holdorf A, Li J, Bromley S, Desai N . A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell. 1998; 94(5):667-77. DOI: 10.1016/s0092-8674(00)81608-6. View

13.

Lai K, Ip N . Synapse development and plasticity: roles of ephrin/Eph receptor signaling. Curr Opin Neurobiol. 2009; 19(3):275-83. DOI: 10.1016/j.conb.2009.04.009. View

14.

Liang Y, Buckley T, Tu L, Langdon S, Tedder T . Structural organization of the human MS4A gene cluster on Chromosome 11q12. Immunogenetics. 2001; 53(5):357-68. DOI: 10.1007/s002510100339. View

15.

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere M . Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009; 41(10):1088-93. PMC: 2845877. DOI: 10.1038/ng.440. View

16.

Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan M . Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet. 2008; 83(5):623-32. PMC: 2668052. DOI: 10.1016/j.ajhg.2008.10.008. View

17.

Peer I, Yelensky R, Altshuler D, Daly M . Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol. 2008; 32(4):381-5. DOI: 10.1002/gepi.20303. View

18.

Ivanov A, Romanovsky A . Putative dual role of ephrin-Eph receptor interactions in inflammation. IUBMB Life. 2006; 58(7):389-94. DOI: 10.1080/15216540600756004. View

19.

Carrasquillo M, Belbin O, Hunter T, Ma L, Bisceglio G, Zou F . Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol. 2010; 67(8):961-4. PMC: 2919638. DOI: 10.1001/archneurol.2010.147. View

20.

Duffy S, Coulthard M, Spanevello M, Herath N, Yeadon T, McCarron J . Generation and characterization of EphA1 receptor tyrosine kinase reporter knockout mice. Genesis. 2008; 46(10):553-61. DOI: 10.1002/dvg.20434. View